These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17850785)

  • 1. Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram.
    Deupree JD; Montgomery MD; Bylund DB
    Eur J Pharmacol; 2007 Dec; 576(1-3):55-60. PubMed ID: 17850785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
    Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [(3)H] citalopram binding to serotonin transporter sites in minnow brains.
    Gould GG; Brooks BW; Frazer A
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):203-10. PubMed ID: 17697042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1.
    Sur C; Betz H; Schloss P
    J Neurochem; 1998 Jun; 70(6):2545-53. PubMed ID: 9603221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of antidepressant binding sites on the recombinant rat serotonin transporter SERT1.
    Schloss P; Betz H
    Biochemistry; 1995 Oct; 34(39):12590-5. PubMed ID: 7548008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of Norepinephrine Transporter Expression and Antidepressant-Like Response to Desipramine in Wild-Type and Serotonin Transporter Mutant Mice.
    Mitchell NC; Bowman MA; Gould GG; Koek W; Daws LC
    J Pharmacol Exp Ther; 2017 Jan; 360(1):84-94. PubMed ID: 27831486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacodynamics of desipramine and desmethyldesipramine in rats.
    Argenti D; D'Mello AP
    J Pharmacol Exp Ther; 1994 Aug; 270(2):512-9. PubMed ID: 7915311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain.
    Gould GG; Javors MA; Frazer A
    Biol Psychiatry; 2007 Jan; 61(2):210-5. PubMed ID: 16650830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters.
    Andersen J; Stuhr-Hansen N; Zachariassen L; Toubro S; Hansen SM; Eildal JN; Bond AD; Bøgesø KP; Bang-Andersen B; Kristensen AS; Strømgaard K
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12137-42. PubMed ID: 21730142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.
    Zhao Z; Baros AM; Zhang HT; Lapiz MD; Bondi CO; Morilak DA; O'Donnell JM
    Neuropsychopharmacology; 2008 Dec; 33(13):3190-200. PubMed ID: 18418364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.
    Zhou Z; Zhen J; Karpowich NK; Goetz RM; Law CJ; Reith ME; Wang DN
    Science; 2007 Sep; 317(5843):1390-3. PubMed ID: 17690258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns.
    Duncan GE; Little KY; Kirkman JA; Kaldas RS; Stumpf WE; Breese GR
    Brain Res; 1992 Sep; 591(2):181-97. PubMed ID: 1332802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants.
    Buck KJ; Amara SG
    Mol Pharmacol; 1995 Dec; 48(6):1030-7. PubMed ID: 8848002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine.
    Bowman MA; Mitchell NC; Owens WA; Horton RE; Koek W; Daws LC;
    Eur J Pharmacol; 2020 Sep; 883():173285. PubMed ID: 32697958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters.
    Andersen J; Kristensen AS; Bang-Andersen B; Strømgaard K
    Chem Commun (Camb); 2009 Jul; (25):3677-92. PubMed ID: 19557250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The allosteric citalopram binding site differentially interferes with neuronal firing rate and SERT trafficking in serotonergic neurons.
    Matthäus F; Haddjeri N; Sánchez C; Martí Y; Bahri S; Rovera R; Schloss P; Lau T
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1806-1817. PubMed ID: 27665061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.
    Pawlowski L; Nowak G; Górka Z; Mazela H
    Psychopharmacology (Berl); 1985; 86(1-2):156-63. PubMed ID: 3927352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].
    Owens JM; Knight DL; Nemeroff CB
    Encephale; 2002; 28(4):350-5. PubMed ID: 12232544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.
    Eildal JN; Andersen J; Kristensen AS; Jørgensen AM; Bang-Andersen B; Jørgensen M; Strømgaard K
    J Med Chem; 2008 May; 51(10):3045-8. PubMed ID: 18429609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function.
    Zhao Y; Sun L
    J Clin Neurosci; 2008 Nov; 15(11):1264-9. PubMed ID: 18815045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.